Recent news on Exjade

My boy was guinea pig  -  25 May 2007
ic SouthLondon.co.uk,An American drug company is testing a drug called Exjade - which clears excess iron from the blood - in Southwark, where Daniel lives.

FDA Warns Of Exjade Problems  -  May 24, 2007
Post ChronicleThe US Food and Drug Administration says it has received reports of kidney failure and deaths possibly associated with Exjade.

FDA - MedWatch - Exjade (deferasorix) Tablets For Oral Suspension ...  -  May 22, 2007
PharmaLive.com (press release),Cases of acute renal failure, some with a fatal outcome, have been reported following the post marketing use of Exjade. Most of the fatalities occurred in

FDA says deaths reported with Novartis' Exjade  -  May 22, 2007
Therapeutics Daily (subscription) (press release),WASHINGTON (Reuters) - Severe kidney failure and some deaths have been reported in patients using Novartis AG's iron overload drug Exjade, the US Food and

Swiss shares close higher, tracking Wall St; Novartis, Nestle in ...  -  May 23, 2007
Forbes,...closing up 0.95 sfr or 1.4 pct at 68.70, bouncing back from a weakness earlier in the day linking its iron-overload drug Exjade with kidney failure.

US diabetes report hits Glaxo shares  -  May 22, 2007
The Herald,...said severe kidney failure and in some cases death have been reported in patients using the iron overload drug Exjade, manufactured by Novartis.

'Shocking' disparity in thalassaemia treatment  -  Apr 30, 2007
Gulf News,...which remove excess iron from the blood due to the frequent blood transfusions, and Exjade - the oral medication alternative to pumps.

Novartis off to a flyer in 2007 thanks to Diovan and Gleevec  -  Apr 24, 2007
Pharma Times (subscription),Exjade (deferasirox), the first once-daily oral iron chelator for chronic iron overload, contributed $65 million to Novartis' coffers. On the negative side,

Novartis Q1 beats forecasts on across-the-board growth; confirms ...  -  Apr 22, 2007
Hemscott,Rapid growth also came from Femara, Xolair, Exjade, Lucentis and Prexige. The first quarter performance also included four important new regulatory

No room for new thalassaemics  -  Apr 19, 2007
The Emirates Evening Post,An alternative that patients can now avail of is the Exjade tablet that can be taken instead of a blood transfusion but residents rue that the cost of this

New data support long term use of once – daily Exjade® to reduce ...  -  Mar 13, 2007
ArabianBusiness.com,New long term efficacy and safety data indicate that once-daily Exjade (deferasirox) continues to reduce total body iron over 2.5 years of treatment in a

SMC Approves Exjade® - No More Needles In Scotland - Good News For ...  -  Feb 13, 2007
Medical News Today (press release),Novartis today welcomed the Scottish Medicines Consortium's acceptance of deferasirox (Exjade®) for use within NHS Scotland for the treatment of iron

Scotland rejects Pfizer's Sutent but backs Novartis' Exjade  -  Feb 13, 2007
Pharma Times (subscription),There was better news for Novartis as the SMC recommended Exjade (deferasirox) for the treatment of iron overload associated with of rare acquired or

Dubai Thalassemia Center Lauded at 5th Middle East Thalassemia ...  -  Feb 18, 2007
Al-Bawaba,Exjade(deferasirox), which can be taken in a drink, removes excess iron from key organs including the liver replacing the use of the cumbersome infusion

Iron-reducing drug passed for use  -  Feb 12, 2007
BBC News,Exjade was launched in the UK in September 2006 but patients in some areas have been having difficulty gaining access to treatment.

Novartis pharma chief sees record number of product launches in 2007  -  18 Jan 2007
Forbes,...several key product roll-outs to take place over the course of next year, such as asthma drug Xolair, and Exjade which counters high iron content.

RPT Novartis pharma chief sees record number of product launches ...  -  18 Jan 2007
Euro2day,...several key product roll-outs to take place over the course of next year, such as asthma drug Xolair, and Exjade which counters high iron content.

Novartis Strategic Healthcare Portfolio Drives Sustained Strong ...  -  18 Jan 2007
PharmaLive.com (press release),New product launches, particularly Xolair, Exjade and Prexige, supported the performance. US net sales were up 17%, outpacing the market.

When wishes come true  -  Jan 10, 2007
Northeast Mississippi Daily Journal,Markell is on the research drug Exjade. It is a once-daily oral iron chelator for the treatment of chronic iron overload due to blood transfusions.

Bernstein Research: Novartis: Comments on the R&D Day  -  Nov 29, 2006
PharmaLive.com (press release),Tekturna (HTN), Exforge (HTN), Tasigna (CML), Aclasta (osteoporosis), Sebivo (hepatitis B), and Exjade (chronic iron overload). Longer-term, we continue

NEW DRUG DELAYS TRANSPLANT OPTION FOR MOIRA BOY  -  Nov 27, 2006
Lisburn Ulster Star,Little Joshua Fletcher (4), a Diamond Blackfan Anaemia sufferer, is currently on a revolutionary new drug, Exjade, which will improve his quality of life.

Novartis Highlights Strong R&D Pipeline, Plans For Multiple New ...  -  Nov 29, 2006
Medical News Today (press release),Exjade (deferasirox) has been launched in the US and Europe as the first and only once-daily oral iron chelator for chronic iron overload in

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional